Press release
Global Buprenorphine Market to Reach USD 14.64 Bn by 2030
Image: https://www.abnewswire.com/upload/2025/03/7720596f3e65e993f3e69f5746c01233.jpg
Global Bamboo Market Key Takeaways
- In terms of Application, the Opioid segment is expected to exhibit the highest share during the forecast period. This is owing to the increasing rate of opioid use disorder among people.
- By route of administration, the sublingual segment is expected to contribute the largest share, driven by extensive usage in the treatment of opioid addiction.
- Based on Distribution Channel, the retail pharmacies segment is projected to hold highest share by 2030, owing to rising rate of new retail pharmacies.
- Coherent Market Insights forecasts that North America will account for 45.1% market share by 2032. The growth is attributed to the rising prescription of Buprenorphine in the region. According to an article published by the American Medical Association, after obtaining license from the US Food and Drug Administration Buprenorphine get the chance to increase access among the drugs.
Request for a sample of this research report @https://www.coherentmarketinsights.com/insight/request-sample/4237
Increasing approval of Buprenorphine treatment and Rising incidences of cancer
A new report by Coherent Market Insights outlines significant trends in the Buprenorphine market. Increasing approval of Buprenorphine treatment will drive demand in the global market during the forecast period. Moreover, the rising prevalence of cancer is also boosting demand in the global market.
Adverse Side effect of Buprenorphine
The global Buprenorphine market growth is hampered by the adverse effects of Buprenorphine during the forecast period. For instance, as per the article published by the National Center of Biotechnology information, the use of Buprenorphine provides some anticholinergic effects that will lead to central nervous system depression. This also led to several side effects such as sweating, dry mouth, miosis, urine retention, nausea, sleepiness, and dizziness.
Opportunities for Growth
The global Buprenorphine market has significant opportunities for growth in emerging countries such as Latin America and Asia Pacific. Factors such as the growing rate of cancer and rising opioid dependency rate in these regions are expected to boost demand in the global Buprenorphine market. Leading countries such as India and Brazil where the healthcare infrastructure is developing use Buprenorphine. Buprenorphine is widely used in pain management and addiction treatment. Additionally, advancements made in the formulation of Buprenorphine like the development of long-acting injectable versions, provide avenues for expansion.
Emerging Market Trends
- Growing adoption of Buprenorphine for the treatment of opioid crisis will drive demand in the global market. Moreover, increasing approval of Buprenorphine-based treatment will boost demand as healthcare providers are now using it as a part of comprehensive addition management programs.
- The rising trend for the development and adoption of long-lasting and extended-release formulations of Buprenorphine. This formulation will help in minimizing the rate of dosing and provide a stable drug level over time.
Analyst's View
"The global Buprenorphine market is poised for notable growth, driven by the increasing rate of people who are suffering from opioid disorder. Medical institutions and doctors are now using Buprenorphine for the treatment of opioid disorders such as opioid addiction," said senior analyst Ghanshyam Shrivastava. "Despite these growth prospectus, the market faces challenge by adverse side effect associated with the use of Buprenorphine."
Competitor Insights
Key companies in Buprenorphine market include:
- Mallinckrodt
- Noramco
- Unichem Laboratories Ltd.
- Sanofi
- Johnson Matthey
- Arevipharma Gmbh
- Resonance Laboratories Pvt Ltd
- Sun Pharmaceutical Industries Limited
- Rusan Pharma Ltd.
- Micro Orgo Chem
- Fran Shimi Pharmaceutical
- Indivior PLC
- Titan Pharmaceutical Inc
- Hikma Pharmaceuticals PLC
Key Development
In January 2025, ZIM Laboratories and Neuraxpharm Group stated that the Committee for Medicinal Products for Human Use will provide authorization to the Neuraxpharm, for Buprenorphine Sublingual Film in Europe.
In May 2023, the U.S. Food and Drug Administration approved Buprenorphine an extended-release injection for subcutaneous use for the treatment of moderate to severe opioid use disorder.
Transform your Strategy with Exclusive Trending Reports:
Dyspareunia Treatment Market [https://www.coherentmarketinsights.com/industry-reports/dyspareunia-treatment-market]
Bacterial Conjunctivitis Drug Market [https://www.coherentmarketinsights.com/market-insight/bacterial-conjunctivitis-drug-market-714]
Lung Cancer Therapeutics Market [https://www.coherentmarketinsights.com/market-insight/lung-cancer-therapeutics-market-702]
About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
Contact Us:
Mr. Raj Shah Senior Client Partner - Business Development Coherent Market Insights
Phone:
US: + 12524771362
UK: +442039578553
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https//www.coherentmarketinsights.com
Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Raj Shah (Senior Client Partner - Business Development)
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-buprenorphine-market-to-reach-usd-1464-bn-by-2030]
Country: United States
Website: https://www.coherentmarketinsights.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Buprenorphine Market to Reach USD 14.64 Bn by 2030 here
News-ID: 3919905 • Views: …
More Releases from ABNewswire
UK Taxpayers Searching for the Highest Rated Tax Software in 2025 Are Choosing P …
Pie Money Limited is a UK-focused fintech company founded by Tommy Mcnally. Headquartered in Dublin, Pie's mission is to make tax simple, stress-free, and accessible. Its services include real-time tax projections, HMRC submissions, compliance support, and smart bookkeeping tools. Fully HMRC-compliant and trusted by thousands across the UK, Pie ensures taxpayers file with confidence and never miss what they're owed.
BIRMINGHAM, United Kingdom - 3 September, 2025 - As more people…
Author Sammy Jo Pendergrast Releases Expanded Second Edition of Bluestar
A reimagined sci-fi epic returns-Sammy Jo Pendergrast releases the definitive 2nd edition of Bluestar.
Image: https://www.abnewswire.com/upload/2025/09/bd5cfaee54f726d44f767c0910049255.jpg
Award-winning storyteller Sammy Jo Pendergrast invites readers back into a galaxy torn apart by war with the newly released second edition of Bluestar . This definitive version of the acclaimed space opera has been expanded by more than 200 pages, enhanced with original chapter artwork, and features a striking new cover design.
Set in the aftermath of…
Blackwell Captive Solutions Partners with Cygenex to Add Genetic Testing to B.We …
New precision medicine capabilities help employers bend the healthcare cost curve through early risk detection.
Blackwell Captive Solutions [https://blackwellcaptive.com/] today announced a new strategic partnership with Cygenex [https://www.cygenex.com/], a leader in advanced diagnostic testing and personalized preventive health solutions. Through this collaboration, Cygenex will become part of B.Well Edge, Blackwell's portfolio of best-in-class solutions designed to help employers proactively manage healthcare costs and improve outcomes.
"B.Well Edge is about giving employers access…
The Next Wave of Functional Flours - Chickpeas, Lentils, Beans & Beyond | A $110 …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030.
According to Arizton research, the global functional flour market [https://www.arizton.com/market-reports/functional-flour-market] was valued at USD 71.34 billion in 2024 and is expected to reach USD 110.93 billion by 2030, growing at a CAGR of 7.63% during the forecast period. The surge in legume-based flours is driving market growth, fueled by the rising demand for gluten-free products, growing…
More Releases for Buprenorphine
Buprenorphine Transdermal Patches Market - Industry Trends and Forecast to 2033
The Buprenorphine Transdermal Patches Market is projected to reach approximately USD 1.05 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2033.
Buprenorphine Transdermal Patches Market Overview
The Buprenorphine Transdermal Patches Market is gaining momentum due to the increasing global incidence of chronic pain and the rising need for effective, long-acting opioid therapies with reduced abuse potential. These patches offer several advantages, including consistent drug…
Buprenorphine Market Next Big Thing | Mallinckrodt, Noramco, Unichem Laboratorie …
Advance Market Analytics published a new research publication on "Buprenorphine Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Buprenorphine market was mainly driven by the increasing R&D spending across the world.
Get inside Scoop of the report, request for free…
Buprenorphine Hydrochloride Market Size, Share, Growth 2031
Global Buprenorphine Hydrochloride Market Size was estimated at USD 138.7 million in 2021 and is projected to reach USD 158.2 million by 2028, exhibiting a CAGR of 1.9% during the forecast period.
The Buprenorphine Hydrochloride Market 2024 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It…
Buprenorphine Market Positioning And Growing Market Share Worldwide Till 2027
Global Buprenorphine Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Buprenorphine Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges. It also highlights the restraints and…
Global Buprenorphine Hydrochloride Market Research Report 2017
Report Hive Market Research Released a New Research Report of 114 pages on Title " Global Buprenorphine Hydrochloride Market Research Report 2017 "with detailed Analysis, Forecast and Strategies.
In this report, the global Buprenorphine Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented…
Global Buprenorphine Hydrochloride Market Research Report 2017
Summary
In this report, the global Buprenorphine Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Buprenorphine Hydrochloride in these regions, from 2012 to 2022 (forecast), covering
North…
